DOI QR코드

DOI QR Code

The Effects of Functional Tea (Mori Folium, Lycii Fructus, Chrysanthemi Flos, Zizyphi Fructus, Sesamum Semen, Raphani Semen) Supplement with Medical Nutrition Therapy on the Blood Lipid Levels and Antioxidant Status in Subjects with Hyperlipidemia

고지혈증 환자에서 의학영양치료와 병행하여 섭취한 기능성차(상엽, 구기자, 국화, 대추, 참깨, 나복자)의 혈중 지질 농도 저하 및 항산화 효과

  • 임현정 (경희대학교 동서의학대학원 의학영양학과) ;
  • 조금호 (경희대학교 임상영양연구소) ;
  • 조여원 (경희대학교 동서의학대학원 의학영양학과, 경희대학교 임상영양연구소)
  • Published : 2005.01.01

Abstract

Hyperlipidemia is one of the risk factors for coronary artery disease. Despite of epidemiological evidence that tea consumption is associated with the reduced risk of coronary heart disease, experimental studies designed to show that drinking tea affects blood lipid concentration or oxidative stress have been unsuccessful. The purpose of this study was to investigate whether functional tea (three servings/day) supplement with medical nutrition therapy (MNT) lead to a beneficial outcomes in mildly hyperlipidemic adults. From February to October, 2003, the 43 hyperlipidemic (23 men, 20 women) subjects (total cholesterol$\geq$200 mg/dL or triglyceride$\geq$150 mg/dL) admitted to K Medical Center were studied. Subjects were randomly divided into 3 groups; placebo tea (PT), half dose of functional tea (HFT), full dose of functional tea (FFT). During 12 weeks of study period, the subjects were given placebo or functional tea daily with MNT. Anthropometric measurements, blood chemical analysis including lipid levels, total superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) levels, and dietary assessment were carried out at the beginning and end of experiment. The effects of functional tea were compared with the placebo in randomized clinical trial study. The placebo was prepared to match with the functional tea in color and taste. After the 12 weeks of MNT, the subjects had regular and balanced meal pattern. Consumption of foods high in cholesterol and saturated fat, salty foods, fried foods, and instant foods decreased significantly in all three groups (p<0.05). Intake of energy and cholesterol also decreased (p<0.05). Drinking three servings per day (390 mL/day) of functional tea significantly reduced the levels of blood triglyceride (HFT, 42.5%; FFT, 29.4%), total cholesterol (HFT, 8.5%; FFT, 13.7%), and atherogenic index (HFT, 14.6%; FFT, 21.7%). Whereas no changes were found in the LDL-, HDL-cholesterollevels, and LDL/HDL ratio. Plasma homocysteine (Hcy) concentration decreased significantly (p<0.05) in functional tea groups (HFT, 14.9%; FFT, 14.1%). SOD increased significantly (p<0.05) in HFT (8.3%). GSH-Px increased significantly (p<0.05) in FFT (12.8%). In conclusion, the MNT improved the dietary habits, in addition, functional tea supplement decreased blood lipid levels and Hcy, and increased SOD and GSH-Px levels. These results indicate that functional tea consumption may decrease the risk of cardiovascular disease via improving blood lipid levels and antioxidant status.

본 연구는 건강검진센터 검진자 중 혈청 중성지방 농도가 150 mg/dL 이상이거나 총 콜레스테롤이 200 mg/dL 이상인 고지혈증 초기 판정자 43명을 대상으로 12주 동안 의학영양치료와 병행하여 한방 기능성 차를 섭취하게 한 후 혈청 지질농도와 항산화에 미치는 영향을 조사한 것이다. 그 결과를 요약하면 다음과 같다. 총 대상자 43명의 평균 연령은 49.41$\pm$5.2세였으며, 남성의 비율이 53.5%였다. 대상자의 51.2%가 혈중 콜레스테를 수치만 높은 제 II a형이었으며, 대상자의 37.2%는 혈중 중성지방과 콜레스테롤이 함께 높은 제IIb형, 11.6%는 중성지방만 높은 제 IV형이었다 모든 대상자는 2003년 건강검진결과 처음으로 고지혈증을 진단받았으며, 지질저하제를 복용하지 않았다. 또한 모든 대상자는 의학영양치료를 받아본 경험이 없었다. 체중은 남여 대상자 모두 군간의 차이가 없었으며, 실험 전과 후의 변화가 관찰되지 않았다. 남성의 경우, 허리둘레가 HFT군에서 유의적으로 감소하였으며, 혈압 또한 HFT군에서 유의적으로 감소하였다. 여성의 경우는 BMI가 FFT군에서 실험 후 유의적으로 감소하였으며, 체지방 비율은 모든 군에서 감소하였다. 식사량, 식사의 규칙성, 식품군의 배합 및 짠 음식 에 대한 기호도 등을 조사한 결과 실험 전 식사량은 만복이 될 때까지 섭취하는 경우가 많았고, 사 시 배합에는 별로 관심이 없었으며, 평균 주 2∼3회의 식사를 거르고 있는 것으로 나타났다. 그러나 실험 후의 이와 같은 양상은 많은 변화를 보였다. 기능성차 섭취와 의학영양치료 전후의 식품 섭취 빈도는 실험 전 콜레스테롤이 많은 음식, 간식의 빈도가 실험 후 유의적으로 감소하였다. 모든 군에서 평균 섭취 열량이 실험 전보다 유의적으로 감소하였다. 총 지방의 섭취량도 유의적으로 섭취 감소를 보였으며, 포화지방산의 경우 HFT군에서 가장 큰 감소를 보였다. 다가 불포화지방산 또한 HFT군에서 감소하였다. 대상자의 P/M/S섭취 비율은 실험 전 0.73/1.l1/1에서 실험 후 0.98/1.38/l로 다가 불포화지방산의 섭취량과 단일 불포화지방산의 섭취 비율이 증가한 것으로 나타났다. 12주간의 식이 콜레스테롤 섭취량도 모든 군에서 매우 큰 감소를 보였다. 혈중 총 콜레스테롤 농도를 비교한 결과 기능성차군에서 유의적으로 감소하였다, 중성지방 농도 또한 총 콜레스테롤 농도와 마찬가지로 기능성차군에서 유의적으로 감소하였다. 혈중 LDL-콜레스테롤과 HDL-콜레스테롤 농도는 실험 전과 후의 유의적인 변화는 없었다, 고지혈증의 발병율과 밀접한 상관관계를 보이는 동맥경화지수는 기능성차군에서 유의적으로 감소하였다. 혈중 호모시스테인 농도의 측정 결과 FFT군의 경우 실험 전 정상범위를 초과하였으나 실험 후 정상 범위에 속하게 되었다. 항산화 물질 2항목(SOD, GPx) 측정결과 SOD는 실험 후 HFT군에서 유의적으로 증가하였다.(13.3%). GPx는 실험 후 FFT군에서 유의적으로 증가되었다.(12.8%). 결론적으로 의학영양치료는 식습관 및 식품섭취의 패턴을 변화시켰고, 총열량과 동물성 단백질, 지방질, 콜레스테롤 섭취의 저하를 유도하였으나 혈중 지질 농도에는 유의적인 변화를 나타내지 못하였다. 그러나 대상자 개인에 맞는 의학영양치료의 적용은 약물요법 이전에 식습관과 섭취량을 조절하는데 매우 유효할 것으로 사료된다. 한편 의학영양치료와 병행한 기능성차(상엽, 구기자, 국화, 대추, 참깨, 나복자가 복합 처방)의 섭취는 혈중 지질 농도를 저하시켰으며, 또한 항산화 효과도 나타내었다. 이와 같이 임상 효능이 확인된 한방재료로 제조된 기능성차의 섭취는 동맥경화증, 허혈성 심장질환, 뇌졸중 등 심혈관계 질환의 주요 원인인 고지혈증에 효과가 있는 것으로 나타났으며, 또한 혈중 지질 농도를 저하시킴으로써 질환을 예방하는데 의학영양치료의 보조적인 역학을 할 수 있는 기능성차로 차별화 될 수 있을 것으로 사료된다.

Keywords

References

  1. Kim JS. 2000. The current status of Korean coronary heart disease. In Diagnosis and treatment in hyperlipidemia. Association of hyperlipidemic therapy, Haneuyhak, Seoul. p 64-74
  2. Summary Report of the Cause of Death Statistics. 2002. Korea National Statistical Office
  3. Grundy SM, Denke MA. 1990. Dietary influence on serum lipids and lipoprotein. J Lipid Res 31: 1149-1172
  4. Barnard RJ, Faria DJ, Menges JE, Martin DA. 1993. Effects of a high-fat, sucrose diet on serum insulin and related atherosclerotic risk factors in rats. Atherosclerosis 100: 229-236 https://doi.org/10.1016/0021-9150(93)90209-D
  5. Parks EJ. 2002. Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations. Br J Nutr 87: 247-253 https://doi.org/10.1079/BJN/2002544
  6. Garg A, Grundy SM, Koffler M. 1992. Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM. Diabetes Care 15: 1572-1580 https://doi.org/10.2337/diacare.15.11.1572
  7. Shin SH. 2000. The choice of medicine. In Diagnosis and treatment in hyperlipidemia. Association of hyperlipidemic therapy, Haneuyhak, Seoul. p 315-331
  8. Jeon KJ, Chung NS, Ahan SG, Ha JW, Lim SJ, Jang YS, Shim WH, Cho SY, Kim SS, Lee SH, Shin MJ. 1999. Studies on the efficacy and safety of Atorva-statin in hypercholesterolemic (LDL-cholesterol) patients. Korean Circulation J 29: 1309-1316 https://doi.org/10.4070/kcj.1999.29.12.1309
  9. Insull W, Kafonek S, Golder D, Zieve F. 2001. Comparison of efficacy and safety of atorvastatin (10 mg) with simvastatin (10 mg) at six weeks. Am J Med 87: 554-559
  10. Hirakawa Y, Shimokawa H. 2001. Lipid-lowering drugs. Nippon Yakurigaku Zasshi 118: 389-395 https://doi.org/10.1254/fpj.118.389
  11. Park JE, Kwon HC. 1995 Cardiovascular risk factors of Koreans. Kor J Lipidol 5: 97-102
  12. Choi YS, Cho SH, Seo JM, Lee NH, Park WH, Song KE. 1999. Effectiveness of nutrition counseling on dietary behavior and serum levels of lipids and antioxidants in patients with cardiovascular disease. Korean J Nutrition 32: 681-690
  13. Kim SJ, Choue RW, Yim JE, Kim YS. 1998. Effects of apo E polymorphisms and dietary counseling on the levels of plasma lipids in hyperlipidemic patients. Korean J Nutrition 31: 1411-1421
  14. Park WH. 1996. A study on the effects of the Pungwidodamtang on high lipid diethyperlipidemia rats. Korean J Oriental Medical Pathology 10: 103-111
  15. Chung MH, Moon YH, Kim GW, Lee BJ. 1991. Effect of Cynanchi wilfordi Radix on experimentally induced hyperlimemia in rats. Kor J Pharmacogn 22: 66-67
  16. Ro HS, Ko WK, Kim OJ, Park KK, Cho YW, Park HS. 1996. Antihyperlipidemic activity of Scutellaris baicalensis Georg, Coptidis japonica Makino and Rhei koreanum Nakai on experimental hyperlipidemia in rats. J Kor Pharm Sci 26: 215-219
  17. Choi MB, Kum SH. 1995. The effect of persicae semen on the hyperlipemia in rabbits. J Herbology 10: 1-11
  18. Kim NJ, Jung EA, Kim DH, Lee SI. 1999. Studies on development of antihyperlipidemic drugs from oriental herbal medicines-antihyperlipidemia activities of oriental herbal medicines-. Kor J Pharmacogn 30: 368-376
  19. Chung MH, Han SJ. 1996. Effect of composite preparation of crude drugs on experimentally induced hyperlipidemia in rats-Sam whang sasim tang and Whang ryun haedok tang. Kor J Phar 27: 397-407
  20. Kim KM, Jeong GS, Kim YG, Kwon JN. 2001. Effects of Whanggikyejiomul-tang on the hyperlipidemia in rats induced by triton WR-1339. Kor J Oriental Medical Physiology & Pathology 15: 531-536
  21. Kim MS, Choue RW, Chung SH, Koo SJ. 1998. Blood glucose lowering effects of mulberry leaves and silkworm extracts on mice fed with high-carbohydrate diet. Korean J Nutrition 31: 117-125
  22. Ro HS, Ko WK, Park KK, Cho YH, Park HS. 1997. Antihyperlipidemic effects of Bupleuri radix, Paeoniae radix and Uncariae ramulus et Uncus on experimental hyperlipidemia in rats. J Appl Phamacol 5: 43-47
  23. Choi DG, Jung HJ, Chang YC, Kang SA, Ahn DK, Park SK. 2002. Effect of Dansamchunghyul-tang on hyperlipidemia on rat. Kor J Oriental Physiology & Pathology 16: 1138-1142
  24. 전국한의과대학심계내과학교실. 1995. 심계내과학. 서원당, 서울. p 212, 506
  25. Committee for establishment of hyperlipidemia therapy guide. 1996. Guideline for hyperlipidemia therapy. 1st ed. p 35
  26. Committee for establishment of hyperlipidemia therapy guide. 2003. Guideline for hyperlipidemia therapy. 2nd ed
  27. Hatch FT. 1968. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6: 1-68 https://doi.org/10.1016/B978-1-4831-9942-9.50008-5
  28. Fletcher MJ. 1968. A colorimetric method for estimating serum triglycerides. Clin Chim Acta 22: 393-397 https://doi.org/10.1016/0009-8981(68)90041-7
  29. Burstein M, Scholnick HR, Morfin R. 1970. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11: 583-595
  30. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499-502
  31. Yim JE, Choue RW, Kim YS, Oh SJ, Paeng JR. 2000. Dietary and simvastatin treatment on the blood lipid levels in the patients with hyperlipidemia according to genetic and biochemical markers. Kor J Lipidol 10: 215-229
  32. Bartesaghi S, Accinni R, Leo GD, Cursano CF, Campolo J, Galluzzo C, Vegezzi PG, Parodi O. 2001. A new HPLC micromethod to measure total plasma homocysteine in newborn. J Pharm Biomed Anal 24: 1137-1141 https://doi.org/10.1016/S0731-7085(00)00573-2
  33. Cornwell PE, Morgan SL, Vaughn WH. 1993. Modification of a high-performance liquid chromatographic method for assay of homocysteine in human plasma. J Chromatogr 617: 136-139 https://doi.org/10.1016/0378-4347(93)80432-4
  34. Arthur JR, Boyne R. 1985. Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle. Life Sci 36: 1569-1575 https://doi.org/10.1016/0024-3205(85)90381-9
  35. McCord JM, Fridovich I. 1969. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055
  36. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169
  37. Kraus RJ, Ganther HE. 1980. Reaction of cyanide with glutathione peroxidase. Biochem Biophys Res Commun 96: 1116-1122 https://doi.org/10.1016/0006-291X(80)90067-4
  38. Yim JE, Choue RW, Kim SJ, Kim YS. 2000. Effects of nutrition therapy and drug treatment on the blood lipid levels in patients with hyperlipidemia according to genetic polymorphism of apo CIII. Korean J Nutrition 33: 813-823
  39. Ministry of health & welfare. 2002. Report on 2001 National Health and Nutrition Survey. Seoul
  40. Hegsted DM, McGandy RB, Myers ML, Stare FJ. 1965. Quantitatie effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 27: 281-295
  41. Mensink RP. 1993. Effects of the individual saturated fatty acids on serum lipids and lipoprotein concentration. Am J Clin Nutr 57: 711s-714s
  42. McPherson R, Spiller GA. 1996. Effects od dietary fatty acids and cholesterol on cardiovascular disease risk factors in man. In Handbook of lipids in human nutrition. Spiller GA, ed. CRC press, Inc., New York. p 41-49
  43. Mata P, Garrido JA, Blazquze E, Alverez-sala LA, Rubio MJ, Alonso R, Oya MD. 1992. Effects of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women. Am J Clin Nutr 56: 77-83
  44. Kastin M, Clifton P, Bellin GB, Nestel PJ. 1990. n-3 fatty acids of marine origin lower systolic blood pressure and triglyceride but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. Am J Clin Nutr 51: 1028- 1034
  45. Schaefer EJ, Rees DG, Siguel EN. 1986. Nutrition, lipoproteins and atherosclerosis. Am J Clin Nutr 5: 99-111
  46. Oh KW, Lee SI, Song KS, Nam CM, Kim YO, Lee YC. 1995. Fatty acid intake patterns and the relation of fatty acid intake to serum lipids of the Korean adults. Kor J Lipidol 5: 167-181
  47. Grundy SM, Ahrens EH Jr. 1970. The effects of unsaturated dietary fats on absorption, excretion, synthesis, and distribution of cholesterol in man. J Clin Invest 49: 1135-1152 https://doi.org/10.1172/JCI106329
  48. Lee IY, Lee IH. 1998. Influence of cardiovascular risk factors on serum lipid levels and fatty acids composition in middle-aged men. Korean J Nutrition 31: 315-323
  49. Kim YH, Paik HY. 1994. Relationship between dietary fatty acids, plasma lipids, and fatty acid compositions of plasma and RBC in young Korean females. Korean J Nutrition 27: 109-117
  50. Lee BK, Chang YK. 1999. Relationships between fatty acid intake and serum lipids in postmenopausal women. Korean J Nutrition 32: 437-447
  51. Lee HY, Kim SK. 1994. Effects fo nutritional status of Korean adults on lipid metabolism with age. Korean J Nutrition 27: 23-45
  52. Mattson FH, Erickson BA, Kligman AM. 1972. Effect of dietary cholesterol on serum cholesterol in man. Am J Clin Nutr 25: 589-594
  53. Hopkins PN. 1992. Effect of dietary cholesterol on serum cholesterol: a metaanalysis and review. Am J Clin Nutr 55: 1060-1070
  54. Gotto AM. 1991. Cholesterol intake and serum cholesterol level. N Engl J Med 28: 912-913
  55. Schomfeld G, Patsch W, Rudel LL, Nelson C, Epstein M, Oslon RE. 1982. Effects of dietary cholesterol and fatty acids on plasma lipoproteins. J Clin Invest 69: 1072-1080 https://doi.org/10.1172/JCI110542
  56. Connor WE, Connor SL. 1982. The dietary treatment of hyperlipidemia; Rationale, technique, and efficacy. Med Clinics North Am 66: 485-518 https://doi.org/10.1016/S0025-7125(16)31432-8
  57. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawker TR. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 62: 707-714 https://doi.org/10.1016/0002-9343(77)90874-9
  58. Gotto AM. 1991. Cholesterol intake and serum cholesterol level. N Engl J Med 28: 912-913
  59. Watts GF, Lewis B, Brunt TNH, Lewis S, Coltart DJ, Smith DR, Mann JI, Swan AV. 1992. Effects on coronary artery desease of lipid lowering diet or diet plus cholestyramine. in the St. Thomas, Atherosclerosis Regression Study (STARS). Lancet 339: 563-569 https://doi.org/10.1016/0140-6736(92)90863-X
  60. Choi YS, Cho SH, Seo JM, Lee NH, Park WH, Song KE. 1999. Effectiveness of nutrition counseling on dietary behavior and serum levels of lipids and antioxidants in patients with cardiovascular disease. Korean J Nutrition 32: 681-690
  61. Diehl HA. 1998. Coronary risk reduction through intensive community based lifestyle intervention: the coronary health improvement project (CHIP) experience. Am J Cardiol 82: 83T-87T https://doi.org/10.1016/S0002-9149(98)00746-2
  62. Sikand G, Kashyap ML, Yang I. 1998. Medical nutrition therapy lowers serum cholesterol and saves medication costs in men with hypercholesterolemia. J Am Dietet Ass 98: 894-899
  63. The Korean Society of Circulation. 1995. Studies on the factors affecting blood lipids distribution in normal Korean. Korean Circulation J 25: 393-403 https://doi.org/10.4070/kcj.1995.25.2.393
  64. Cho JH, Nam MS, Lee EJ, Oh SC, Kim KR, Lim SK, Lee HC, Huh KB, Lee SI, Lee KW. 1994. The level of serum total cholesterol and triglyceride in healthy Korean adults. Kor J Lipidol 4: 182-189
  65. Yoo WS. 2000. The epidemiology of hyperlipidemia. In Diagnosis and treatment in hyperlipidemia. Association of hyperlipidemic therapy, Haneuyhak, Seoul. p 59
  66. Hwang GH, Noh YH, Heo YR. 1999. A study on hyperlipidemia in Koreans-specially related to hematological characteristics and risk factors of hypercholesterolemia-. J Korean Soc Food Sci Nutr 28: 710-721
  67. Chen F, Nakashima N, Kimura I, Kimura M, Asano N, Koya S. 1995. Potentiating effects on pilocarpine-induced saliva secretion, by extracts and N-containing sugars derived from mulberry leaves, in streptozotocin-diabetic mice. Biol Pharm Bull 18: 1676-1680 https://doi.org/10.1248/bpb.18.1676
  68. Chen F, Nakashima N, Kimura I, Kimur M. 1995. Hypoglycemic activity and mechanism of extracts from mulberry leaves (Folium Mori) and cortex mori radicis in streptozotocin induced diabetic mice. Yakugaku Zasshi 115: 476-482 https://doi.org/10.1248/yakushi1947.115.6_476
  69. Kim HC. 2001. Textbook of herbal pharmacology. Jib mun dang press, Seoul. p 105-106
  70. Youna WG, Kim NJ, Hong ND. 1994. Pharmacological effects of Lycium chinense. Kor J Pharmacogn 25: 264-271
  71. 신민교. 1991. 임상본초학. 영림출판사, 서울. p 169, 174, 254, 233, 518
  72. 顔正華 主編. 1991. 中藥學. 人民衛生出版社, 北京. p 65, 70, 160, 737, 760
  73. Kim SY, Lee YC, Cho SY. 1999. Serum fatty acids in patients with angiographically-documented coronary artery disease. Korean J Nutrition 32: 166-174
  74. Yamajaki K, Murata M. 1990. Frequency of atherogenic risk factors in Japanese obese children. Diabetes Res Clin Pract 10: s211-s219 https://doi.org/10.1016/0168-8227(90)90166-Q
  75. McCully KS. 1969. Vascular pathology of homocysteinemia: implications for pathogenesis of arteriosclerosis. Am J Pathol 56: 111-128
  76. Welch GN, Loscalzo J. 1998. Homocysteine and atherothrombosis. N Engl J Med 338: 1042-1050 https://doi.org/10.1056/NEJM199804093381507
  77. Malinow MR, Bostom AG, Krauss RM. 1999. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99: 178-182 https://doi.org/10.1161/01.CIR.99.1.178
  78. Yoo SK, Lee SJ. 2002. Effects of YK-209 mulberry leaves on antioxidative defense system of liver in streptozotocin-induced diabetic rats. J Korean Soc Food Sci Nutr 31: 1065-1070 https://doi.org/10.3746/jkfn.2002.31.6.1065

Cited by

  1. Reduction of Plasma Triglycerides and Cholesterol in High Fat Diet-Induced Hyper-Lipidemic Mice by n-3 Fatty Acid from Bokbunja (Rubus coreanus Miquel) Seed Oil vol.44, pp.7, 2015, https://doi.org/10.3746/jkfn.2015.44.7.961
  2. Blood Flow Improvement Effect of Bokbunja (Rubus coreanus) Seed Oil in High-Fat Diet-Fed Mouse Model vol.44, pp.8, 2015, https://doi.org/10.3746/jkfn.2015.44.8.1105
  3. Effects of Dietary Kugija Lycium chinense Supplementation on Juvenile Korean Rockfish Sebastes schlegeli vol.42, pp.3, 2009, https://doi.org/10.5657/kfas.2009.42.3.250
  4. Effects of Kangjieum on Serum Lipids and Active Oxygen Content in Overweight Women Consequential Qi-stagnation and Blood Stasis Patterns vol.25, pp.4, 2012, https://doi.org/10.9799/ksfan.2012.25.4.697
  5. Quality Characteristics of Mungbeanmook Added with Gugija (Lycii fructus) Infusion vol.18, pp.3, 2012, https://doi.org/10.14373/JKDA.2012.18.3.213
  6. Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients vol.28, pp.11, 2008, https://doi.org/10.1016/j.nutres.2008.08.005
  7. Profiling of flavonoid glycosides in fruits and leaves of jujube (Zizyphus jujuba var. inermis (Bunge) Rehder) using UPLC-DAD-QTOF/MS vol.23, pp.7, 2016, https://doi.org/10.11002/kjfp.2016.23.7.1004
  8. Ameliorative effect of saltwort (Salicornia herbacea) extract on hepatic dysfunction and hyperlipidemia in rats vol.21, pp.2, 2012, https://doi.org/10.1007/s10068-012-0044-y
  9. 홍화씨와 한약재 흔합추출물이 Streptozotocin으로 유도한 흰쥐의 혈당과 혈액 성분에 미치는 영향 vol.35, pp.2, 2005, https://doi.org/10.3746/jkfn.2006.35.2.150
  10. 건강과 질병치료 효능 증진을 위한 한방영양과 현대영양관리의 비교 vol.35, pp.8, 2005, https://doi.org/10.3746/jkfn.2006.35.8.1106
  11. 건강과 질병치료 효능 증진을 위한 한방영양과 현대영양관리의 비교 vol.35, pp.8, 2005, https://doi.org/10.3746/jkfn.2006.35.8.1106
  12. 금은화, 황련, 상엽 추출물 혼합물과 항생제(Albac G150) 급여가 계육의 산화 안전성에 미치는 영향 vol.35, pp.1, 2005, https://doi.org/10.5536/kjps.2008.35.1.029
  13. Streptozotocin으로 유발된 흰쥐에 대한 구기자 추출물의 혈당강하 및 항산화 작용에 미치는 효과 vol.25, pp.1, 2005, https://doi.org/10.12925/jkocs.2008.25.1.10
  14. HK-1000 약침이 흰쥐의 고지혈증 및 동맥경화증에 미치는 영향 vol.11, pp.3, 2005, https://doi.org/10.3831/kpi.2008.11.3.055